SKI Market

Indian Indices

Sensex

82,814.71 316.57
( 0.38%)

Global Indices

Nasdaq

49,649.56 233.39
(0.47%)

Dow Jones

6,930.29 47.40
(0.69%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,691.66 64.62
(0.61%)

Forex

USD-INR

91.03 0.34
(0.37%)

EUR-INR

107.23 0.00
(0.00%)

GBP-INR

122.67 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

267.3488556

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

29.55

14995.8

EPS(TTM)

Face Value()

Div & Yield %

25.82

1.44

Back

S H Kelkar & Company consolidated net profit declines 76.92% in the September 2025 quarter

Nov 08,2025

Net profit of S H Kelkar & Company declined 76.92% to Rs 9.18 crore in the quarter ended September 2025 as against Rs 39.78 crore during the previous quarter ended September 2024. Sales rose 2.22% to Rs 551.63 crore in the quarter ended September 2025 as against Rs 539.66 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	551.63	539.66	2
OPM %	9.50	14.85	-
PBDT	38.80	87.95	-56
PBT	11.42	63.77	-82
NP	9.18	39.78	-77

82,814.71 316.57 ( 0.38%)

49,649.56 233.39 (0.47%)

6,930.29 47.40 (0.69%)

56,838.27 -629.56 (-1.10%)

10,691.66 64.62 (0.61%)

91.03 0.34 (0.37%)

107.23 0.00 (0.00%)

122.67 -0.16 (-0.13%)

0.59 0.00 (-0.25%)